Galectin Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.64

-0.33 (-6.64%)

As of Jun 30, 10:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +179.3% upside

Low Target $9.51

Average Target $12.96

High Target $17.52

Current Price $4.64

Current
$4.64

Target
$12.96

$9.51 $12.96 avg $17.52

Scenario Analysis

Bear Case

$9.51

105.0%

Low target

Base Case

$12.96

+179.3%

Avg target

Bull Case

$17.52

+277.6%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$7.13

-34.9% from high

52-Week Low

$2.03

+129.1% from low

Target vs 52W High

$12.96

+81.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%